As shown in Figure 5A, addition of Romidepsin and ACY-1215 to gemcitabine markedly enhanced apoptosis in pancreatic cancer cells, as indicated by PARP and caspase 3 cleavage as well as Annexin V staining (Figure 5Ai,ii). The gene discussed is CASP3; the disease is familial pancreatic carcinoma.